Skip to main content

Table 4 Response details

From: Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid

Patient

Cytologic response (blast count) (%)

Hematological improvement

Cytogenetic response

Response FISH-BM (%)

Response FISH-CD34 (%)

Mito response (%)

F03

CRi

HI-P

CR

nd

CR

na

D01

PR (5)

HI-N, HI-P, HI-E

nd

nd

nd

nd

D03

CRdys

HI-N, HI-P, HI-E

na

na

na

na

D04

CRdys

HI-N, HI-P, HI-E

CR

CR

CR

na

D05

CR

HI-N, HI-P

CR

CR

PR (1)

PR (5)

D06

CRdys

HI-P

CR

CR

PR (5)

na

D14

CRdys

None

na

na

na

na

D15

PR (5)

HI-P, HI-E

CR

PR (6)

CR

CR

D17

CRdys

HI-N, HI-P, HI-E

CR

CR

CR

CR

F02

SD (CMR)

None

na

na

na

na

F05

SD (CMR)

None

None

nd

none

na

D11

SD (CMR)

None

None

none

none

None

D13

SD (PMR)

None

na

na

na

None

  1. nd not done, na not applicable